Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Day One Biopharmaceuticals (DAWN) Shares Issued (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Shares Issued for 4 consecutive years, with -$748000.0 as the latest value for Q4 2025.

  • For Q4 2025, Shares Issued rose 23.12% year-over-year to -$748000.0; the TTM value through Sep 2025 reached -$225000.0, down 123.12%, while the annual FY2023 figure was $1.3 million, N/A changed from the prior year.
  • Shares Issued was -$748000.0 for Q4 2025 at Day One Biopharmaceuticals, down from $748000.0 in the prior quarter.
  • The five-year high for Shares Issued was $161.6 million in Q2 2022, with the low at -$160.1 million in Q3 2023.
  • Historically, Shares Issued has averaged $111500.0 across 4 years, with a median of $186000.0 in 2024.
  • Biggest YoY gain for Shares Issued was 100.38% in 2024; the steepest drop was 99.8% in 2024.
  • Over 4 years, Shares Issued stood at -$2.1 million in 2022, then plummeted by 7696.49% to -$160.1 million in 2023, then soared by 99.39% to -$973000.0 in 2024, then grew by 23.12% to -$748000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$748000.0 in Q4 2025, $748000.0 in Q3 2025, and -$973000.0 in Q4 2024.